NDC 64850-892

Loxapine

Loxapine

Loxapine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Elite Laboratories, Inc.. The primary component is Loxapine Succinate.

Product ID64850-892_1ae345d7-3740-4f9f-9046-16c9dddcc543
NDC64850-892
Product TypeHuman Prescription Drug
Proprietary NameLoxapine
Generic NameLoxapine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-01-27
Marketing CategoryANDA / ANDA
Application NumberANDA076868
Labeler NameElite Laboratories, Inc.
Substance NameLOXAPINE SUCCINATE
Active Ingredient Strength25 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 64850-892-01

100 CAPSULE in 1 BOTTLE (64850-892-01)
Marketing Start Date2020-01-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Loxapine" or generic name "Loxapine"

NDCBrand NameGeneric Name
0378-7005Loxapineloxapine
0378-7010Loxapineloxapine
0378-7025Loxapineloxapine
0378-7050Loxapineloxapine
0527-1394LoxapineLoxapine
0527-1395LoxapineLoxapine
0527-1396LoxapineLoxapine
0527-1397LoxapineLoxapine
0591-0369LoxapineLoxapine
0591-0370LoxapineLoxapine
0591-0371LoxapineLoxapine
0591-0372LoxapineLoxapine
10135-585LoxapineLoxapine succinate
10135-586LoxapineLoxapine succinate
10135-587LoxapineLoxapine succinate
10135-588LoxapineLoxapine succinate
17856-1397LoxapineLoxapine
35573-436LoxapineLoxapine
35573-437LoxapineLoxapine
35573-438LoxapineLoxapine
35573-439LoxapineLoxapine
50090-3099LoxapineLoxapine
50090-3457Loxapineloxapine
50090-4701LoxapineLoxapine
51079-901Loxapineloxapine
68151-2875LoxapineLoxapine
70518-0283LoxapineLoxapine
70518-0347LoxapineLoxapine
70518-0416LoxapineLoxapine
70518-0995LoxapineLoxapine
70518-0346LoxapineLoxapine
70518-1681LoxapineLoxapine
70518-1896LoxapineLoxapine
70518-1792LoxapineLoxapine
51079-902LoxapineLoxapine
51079-903LoxapineLoxapine
70518-2120LoxapineLoxapine
10885-003Adasuveloxapine
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.